Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC)
Aims The present study was performed to investigate the efficacy and safety of anti-programmed death-1 (PD-1)/programmed death-ligand-1 (PD-L1) treatments in non-small cell lung cancer (NSCLC).Methods The potential articles were searched from Pubmed and Embase. The end points included overall surviv...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2019-12-01
|
| Edice: | Artificial Cells, Nanomedicine, and Biotechnology |
| Témata: | |
| On-line přístup: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1687499 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|